Alkem Laboratories Bilan de santé
Santé financière contrôle des critères 6/6
Alkem Laboratories possède un total de capitaux propres de ₹119.1B et une dette totale de ₹12.4B, ce qui porte son ratio d'endettement à 10.4%. Son actif total et son passif total sont ₹171.2B et de ₹52.1B. L'EBIT de Alkem Laboratories est ₹23.1B ce qui fait que son ratio de couverture des intérêts -11.6. Elle dispose de liquidités et de placements à court terme de ₹22.9B.
Informations clés
10.4%
Ratio d'endettement
₹12.36b
Dette
Ratio de couverture des intérêts | -11.6x |
Argent liquide | ₹22.89b |
Fonds propres | ₹119.10b |
Total du passif | ₹52.07b |
Total des actifs | ₹171.17b |
Mises à jour récentes de la santé financière
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Recent updates
Alkem Laboratories Limited Recorded A 5.4% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 16Here's Why We Think Alkem Laboratories (NSE:ALKEM) Is Well Worth Watching
Nov 15What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You
Sep 24Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 03Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 27Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00
Jul 13Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 27Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00
Jun 13Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Jun 01Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)
May 22Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Analyse de la situation financière
Passif à court terme: Les actifs à court terme de ALKEM ( ₹111.1B ) dépassent ses passifs à court terme ( ₹41.8B ).
Passif à long terme: Les actifs à court terme de ALKEM ( ₹111.1B ) dépassent ses passifs à long terme ( ₹10.3B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ALKEM dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de ALKEM a été réduit de 23.5% à 10.4% au cours des 5 dernières années.
Couverture de la dette: La dette de ALKEM est bien couverte par le flux de trésorerie opérationnel ( 158.1% ).
Couverture des intérêts: ALKEM gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.